Esma navigates a Brexit maze over equivalence
Regulator offers share-trading reprieve for EU firms without relaxing rules for UK
In March, Risk.net heard stories of decision-making on equivalence at the European Securities and Markets Authority being paralysed by concerns that a generous equivalence regime could weaken the negotiating hand of the EU 27 in Brexit talks.
It now seems Esma has managed to solve this conundrum, at least in regard to allowing European Union firms to continue trading shares on third-country venues.
Unfortunate wording in the Markets in Financial Instruments Regulation (Mifir) will bar EU investment firms from trading any shares on non-equivalent third-country venues once the rule takes effect on January 3.
The rule, known as the share-trading obligation, stipulates that if shares are traded in the European Economic Area, Mifid-regulated investment firms can only trade them on EEA-regulated markets or multilateral trading facilities, with an EEA systematic internaliser or on a third-country venue deemed equivalent by the European Commission (EC).
With time running out, there is uncertainty around which jurisdictions will be granted equivalence in time for the start of Mifir. So far, the only official, positive EU equivalence announcement has been a broad agreement with the US for the derivatives-trading obligation.
The risks of delayed equivalence decisions are particularly acute for non-EEA equities that have some limited trading in the EEA, but a much larger liquidity pool located elsewhere. This category would mainly consist of dual-listed stocks and EEA-listed depository receipts of third-country issuers, but could in practice affect many other shares, which are very marginally traded on a single EU venue.
Industry players have put forward various workarounds of the obligation, capitalising on different interpretations of Mifir. For example, EU authorities could clarify best execution overrides the share-trading obligation.
This kind of approach would have allowed trading on non-equivalent third-country venues to continue in some form. But it could potentially weaken the trading obligation overall, making it easier for EU investment firms to trade in the UK after Brexit, even if the British regulatory regime diverges from Mifir.
Esma has opted for its own legal solution that hinges on an undefined exemption to the share-trading obligation
Instead, Esma has opted for its own legal solution that hinges on an undefined exemption to the share-trading obligation. This allows trading on non-equivalent third-country venues if it is “non-systematic, ad hoc, irregular and infrequent”.
In a press release published on November 13, Esma stated if the EC has not made an equivalence determination for a jurisdiction, it indicates there is “no evidence that the EU trading in shares admitted to trading in that third country’s regulated markets can be considered as systematic, regular and frequent”.
Normal service?
So unless the EC explicitly states a jurisdiction is not equivalent, trading can continue as normal on those jurisdictions without an equivalence decision, on the basis that current EU trading flows on those venues are insignificant.
This cute interpretation of the law is welcome for market participants, as it means they can still trade shares on venues for which the EC has not yet been able to make an equivalence decision in time for the start of Mifir.
And yet it also leaves EU authorities with the option of using the share-trading obligation to prevent EU investment firms trading any shares on specific third-country venues, even in the absence of an equivalence decision.
There is no definition or threshold for trading activity that meets the “non-systematic, irregular and infrequent” criteria. But London-based Cboe Europe, for instance, routinely reports market shares for trading in French and German stocks at more than 20%. It would be a brave investment firm that tried to tell Esma this was “irregular and infrequent” trading in an attempt to benefit from this newly minted exemption. This keeps share-trading venue equivalence as a Brexit bargaining chip in EU negotiators’ hands.
コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。
これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe
現在、このコンテンツを印刷することはできません。詳しくはinfo@risk.netまでお問い合わせください。
現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。
Copyright インフォプロ・デジタル・リミテッド.無断複写・転載を禁じます。
当社の利用規約、https://www.infopro-digital.com/terms-and-conditions/subscriptions/(ポイント2.4)に記載されているように、印刷は1部のみです。
追加の権利を購入したい場合は、info@risk.netまで電子メールでご連絡ください。
Copyright インフォプロ・デジタル・リミテッド.無断複写・転載を禁じます。
このコンテンツは、当社の記事ツールを使用して共有することができます。当社の利用規約、https://www.infopro-digital.com/terms-and-conditions/subscriptions/(第2.4項)に概説されているように、認定ユーザーは、個人的な使用のために資料のコピーを1部のみ作成することができます。また、2.5項の制限にも従わなければなりません。
追加権利の購入をご希望の場合は、info@risk.netまで電子メールでご連絡ください。
詳細はこちら 我々の見解
批判派は、パーペチュアルはすべてフロスだと言っています。しかし、数字はそうではないことを示唆している
TradFiを原資産とする永久先物に対する堅調な未決済建玉は、CMEやEurexといった既存の取引所にとって脅威となる可能性があります
SpaceXがCMEの個別銘柄先物に待望の追い風をもたらした
S&P 500先物契約へのIPO関連の追加契約として、新たな契約が急増する可能性があります
Bank vs non-bank: FX’s two-tier reality
CME and LSEG data show banks provide sticky and broad liquidity, while non-banks cling tightly to the price
規制当局はエンフォースメントを甘くしているのか?(そして、私たちはそれを気にするべきなのか?)
米国の規制当局は、技術的な規則違反に対する罰則を緩和しており、小さくとも重要なリスクが見過ごされてしまうのではないかという懸念が高まっています
FX HedgePoolを超えて:オール・トゥ・オール(All-to-All)の今後はどうなる?
この取引モデルの支持者たちは、その将来性を明るく見ていますが、普及に向けた障壁は依然として残っています。
バーゼル協定のCVA見直し:米国では説得力があるものの、欧州ではそれほどではない
信用リスクモデルの使用禁止は、米国の銀行がより高度なCVA手法を採用するきっかけとなる可能性があります
オルタナティブ・データは予測市場に賭けているのか?
新たなデータの豊富な情報源を提供する一方で、法的な不確実性は依然として残っています
「SaaSpocalypse」は、プライベート市場にリスクモデルが必要であることを示している
投資家たちは、プライベート・クレジットにおける損失がどれほど深刻なものになるか、ほとんど見当がつかない